Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for treatment engagement in alcohol-dependent veterans
NCT01856712Phase 3Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in alcohol dependence, sponsored by University of Wisconsin–Madison. Started May 2013; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01856712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856712.